Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLIMR COPD: Tirzepatide for Lung Function and Muscle Restoration in COPD
NCT07747805Phase 2Not yet recruiting
- Sponsor
- Cleveland Clinic
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in chronic obstructive pulmonary disease (COPD), sponsored by Cleveland Clinic. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07747805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747805.